Therapy of adult ITP before splenectomy.

Slides:



Advertisements
Similar presentations
Plasma Exchange consists of the removal of large volumes of the patient' s plasma and replacing it with exogenous plasma or plasma substitutes Action:
Advertisements

Idiopathic Thrombocytopenic Purpura
» Surface Relations ˃Stomach ˃Renal ˃Colon » Suspended by ˃Phrenosplenic ligament ˃Gastrosplenic ligament ˃Splenocolic ligament ˃Gastrocolic ligament.
Heather D. Mannuel, MD, MBA March 12, 2008
Teaching Liver cirrhosis with varices. Discussion  Approximately half of patients with cirrhosis have esophageal varices  One-third of all patients.
Leadership. Knowledge. Community. Canadian Cardiovascular Society Antiplatelet Guidelines MANAGEMENT OF ANTIPLATELET THERAPY IN ASSOCIATION WITH MINOR.
SUA
IMMUNE THROMBOCYTOPENIA Cathy Payne MSN, ACNP-BC Hematology/Oncology Nurse Practitioner Ironwood Cancer and Research Centers.
ITP in the adult Blood.2011;117(16): Presentor: 周益聖 Instructor: 蕭樑材 財團法人台灣癌症臨床研究發展基金會.
MTP Octaplex rFVIIa Calgary. Massive Transfusion Protocol.
ITP Immune (Idiopathic) Thrombocytopenic Purpura AM Report 5/25/2010.
THROMBOCYTOPENIA - reduced platelet count -. First of all.. what are platelets? Platelets: tiny cells that circulate in the blood and whose function is.
Autoimmune Idiopathic Thrombocytopenic Purpura (ITP) Nicola Davis.
November 23, Idiopathic Throbocytopenic Purpura.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Exercise Management Cancer. Pathophysiology Cancer is not a single disease; it is a collection of hundreds of diseases that share the common feature of.
Assessing Control & Adjusting Therapy in Youths > 12 Years of Age & Adults *ACQ values of 0.76–1.4 are indeterminate regarding well-controlled asthma.
Component 4 Medications. Key Points - Medications  2 general classes: – Long-term control medications – Quick-Relief medications  Controller medications:
Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura by Donald M. Arnold, Ishac Nazi, Aurelio Santos,
Blood : R2 임규성.  Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by low platelet counts and may be responsible.
Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura Journal.
Dr. A. Carrer Clinica Ematologica ASST- Monza IT P.
Done by : Ahmed Fahad Basilim clinical pharmacist intern Supervised by: Dr. Muna Filfilan.
NEONATAL IMMUNE THROMBOCYTOPENIA
Thrombocytopenia Allen Chang, PGY2 5/18/15.
Myelodysplastic Syndromes
CD4+ T-lymphocyte count <100 cells/µl
Warfarin Toxicity Treatment & Management
by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and
DIATHESIS HAEMORRHAGIS.
A Randomized Trial Of Daily Prednisone Versus Pulsed Dexamethasone In Treatment Naïve Patients With Idiopathic Thrombocytopenic Purpura by Johannes Matschke,
Immunosurveillance of Alglucerase Enzyme Therapy for Gaucher Patients: Induction of Humoral Tolerance in Seroconverted Patients After Repeat Administration.
Triple play of H pylori in ITP
by Henrik Frederiksen, and Kai Schmidt
Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants by Rachael P. Jackman, Xutao Deng, Douglas Bolgiano, Mila.
How I treat autoimmune hemolytic anemias in adults
How I treat patients with massive hemorrhage
How I treat elderly patients with myeloma
Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to.
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with.
Myelodysplastic Syndromes
by Rong Deng, and Joseph P. Balthasar
Reversal of Direct Oral Anticoagulants (DOAC)
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation by Bethan Psaila, James B. Bussel, Matthew.
VTE in Cancer.
ROCK and Rho(ll) in bone marrow
Blocking VWF platelet binding to treat TTP
by Jon E. Arnason, Federico Campigotto, Donna Neuberg, and James B
IMMUNE THROMBOCYTOPENIC PURPURA MBBSPPT.COM
Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? by Marc Michel, Nichola Cooper, Christelle Jean, Christine Frissora, and.
Letermovir(Prevymis™) Guidelines for Inpatient Use
Figure 2 Clinical course and response to therapy in 6 Australian patients with HMGCR antibodies The clinical course, creatine kinase (CK) levels, Medical.
How I treat cancer-associated venous thromboembolism
Pomalidomide plus Low-Dose Dexamethasone in Myeloma Refractory to Both Bortezomib and Lenalidomide: Comparison of Two Dosing Strategies in Dual-Refractory.
Predicted number of joint bleeds according to factor activity level and age group for patients with hemophilia A or B based on a regression model. Predicted.
Chronic ITP Debates & Dilemmas
Evaluation and Management of Pediatric Seizures
Figure Clinical course and overview of the treatment protocols♦ = neuroradiologic evidence of new disease activity; ★ = CD19+ reconstitution. Clinical.
Blood Components Dosage And Their Administration
Efficacy of immunomodulation in the treatment of profound thrombocytopenia after adult cardiac surgery  J. Scott Rankin, MD, Charles W. Stratton, MD 
How I treat thrombocytopenia in pregnancy
Algorithm based on the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of polymyalgia.
Northern Cancer Alliance Colorectal Symptoms Assessment Pathway
An algorithmic approach to FL
Durability of response after horse ATG
Current standard of care treatment protocols for LN induction therapy.
How I treat heparin-induced thrombocytopenia and thrombosis
Treatment algorithm. Treatment algorithm. (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE in cancer patients. (B) Suggested.
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment by Waleed Ghanima, Bertrand Godeau,
Cumulative prevalence of venous thromboembolic events in ITP patients who underwent splenectomy compared with those who did not. Cumulative prevalence.
Presentation transcript:

Therapy of adult ITP before splenectomy. Therapy of adult ITP before splenectomy. (1) Minimal emergent therapy includes IV methylprednisolone and IVIG. IV anti-D and platelet transfusions may be given as needed; repeated or continuous platelet transfusions may be required in urgent situations; all 3 modalities given prior to transfusions may help preserve their longevity in the circulation. (2) We generally initiate therapy with prednisone and add either IV anti-D (in Rh+, direct antiglobulin-negative patients) or IVIG as needed for persistent severe thrombocytopenia with the goal of attaining a platelet count of greater than 30 000 × 109/L and cessation of bleeding. Details of therapy and duration of treatment are discussed in text. (3) Thrombocytopenia recurs in most adults as corticosteroids are tapered. The treatment modality depends on the severity of the thrombocytopenia and bleeding, tolerance of treatment, and patient preference as discussed in “Initial therapy for nonemergent indications.” We would generally treat for a minimum of 3 months and a maximum of 12 months, barring evidence of late improvement, before considering splenectomy. (4) We recommend splenectomy for those clearly requiring therapy beyond 12 months to maintain a hemostatic platelet count and sooner in select individuals intolerant of therapy, with active lifestyles or comorbid risk factors that make higher platelet counts desirable. po indicates orally; prn, as needed; and q, every. Douglas B. Cines, and James B. Bussel Blood 2005;106:2244-2251 ©2005 by American Society of Hematology